Barclays PLC Catalyst Biosciences, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$0.19 - $0.64 $5,719 - $19,265
30,102 Added 100.0%
60,204 $12,000
Q4 2021

Feb 14, 2022
SELL
$0.91 - $4.16 $3,410 - $15,591
-3,748 Reduced 11.07%
30,102 $28,000
Q3 2021

Nov 09, 2021
BUY
$3.78 - $5.18 $824 - $1,129
218 Added 0.65%
33,850 $139,000
Q2 2021

Aug 13, 2021
SELL
$4.1 - $5.33 $91,056 - $118,373
-22,209 Reduced 39.77%
33,632 $145,000
Q1 2021

May 13, 2021
BUY
$4.93 - $7.15 $131,966 - $191,391
26,768 Added 92.07%
55,841 $282,000
Q4 2020

Feb 11, 2021
SELL
$4.55 - $7.29 $13,358 - $21,403
-2,936 Reduced 9.17%
29,073 $183,000
Q3 2020

Nov 12, 2020
BUY
$4.22 - $6.04 $65,025 - $93,070
15,409 Added 92.83%
32,009 $137,000
Q2 2020

Aug 12, 2020
BUY
$3.76 - $8.01 $62,299 - $132,717
16,569 Added 53448.39%
16,600 $97,000
Q1 2020

May 13, 2020
SELL
$3.5 - $8.51 $2,828 - $6,876
-808 Reduced 96.31%
31 $0
Q4 2019

Feb 10, 2020
SELL
$4.52 - $7.91 $4,944 - $8,653
-1,094 Reduced 56.6%
839 $6,000
Q3 2019

Nov 14, 2019
SELL
$4.91 - $9.31 $163,016 - $309,101
-33,201 Reduced 94.5%
1,933 $9,000
Q2 2019

Aug 14, 2019
BUY
$7.08 - $10.6 $222,765 - $333,518
31,464 Added 857.33%
35,134 $259,000
Q1 2019

May 15, 2019
BUY
$7.67 - $9.96 $25,257 - $32,798
3,293 Added 873.47%
3,670 $29,000
Q4 2018

Feb 14, 2019
SELL
$6.59 - $11.28 $121,229 - $207,506
-18,396 Reduced 97.99%
377 $3,000
Q3 2018

Nov 14, 2018
SELL
$9.35 - $12.44 $188,159 - $250,342
-20,124 Reduced 51.74%
18,773 $202,000
Q2 2018

Aug 14, 2018
BUY
$9.11 - $28.88 $327,641 - $1.04 Million
35,965 Added 1226.64%
38,897 $454,000
Q1 2018

May 15, 2018
BUY
$14.18 - $35.6 $36,868 - $92,560
2,600 Added 783.13%
2,932 $76,000
Q4 2017

Feb 14, 2018
BUY
$4.52 - $13.69 $1,355 - $4,107
300 Added 937.5%
332 $5,000
Q3 2017

Nov 14, 2017
BUY
$3.19 - $5.1 $102 - $163
32
32 $0

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email